Cancer immunotherapy, focusing on breaking tumor microenvironment (TME) immunosuppression, is limited by heterogeneity and drug resistance. Exosomes, 30-150 nm extracellular vesicles(EVs) carrying proteins, lipids, and noncoding RNAs, mediate intercellular com... ...
